Who owns ANEBULO PHARMACEUTICALS INC?
- Ticker: ANEB
- CUSIP Number: 034569103
Tip: Access positions for across all investors
Analyze quarterly positions in Anebulo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Anebulo Pharmaceuticals stock
Who bought or sold ANEBULO PHARMACEUTICALS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| 22NW | 16M | $26M | 188% | Dec 2024 |
|
| Nantahala Capital Management | 3.0M | $5.1M | 494% | Dec 2024 |
|
| Mangrove Partners | 2.5M | $3.6M | 100% | Dec 2024 |
|
| Morgan Stanley | 420k | $706k | 5% | Dec 2024 |
|
| LVW Advisors | 350k | $455k | -45% | Mar 2025 |
|
| Ikarian Capital | 158k | $265k | 0% | Dec 2024 |
|
| Vanguard Group | 154k | $259k | 0% | Dec 2024 |
|
| Geode Capital Management | 91k | $154k | 4% | Dec 2024 |
|
| Luther King Capital Management Corporation | 60k | $100k | 100% | Dec 2024 |
|
| Boothbay Fund Management | 19k | $32k | -1% | Dec 2024 |
|
| BlackRock | 3.9k | $6.6k | 1% | Dec 2024 |
|
| Tower Research Capital | 3.3k | $5.6k | 23% | Dec 2024 |
|
| Bank of America Corporation | 76.00 | $127.999200 | 0% | Dec 2024 |
|
| UBS Group | 25.00 | $42.000000 | -97% | Dec 2024 |
|
| Jpmorgan Chase & Co | 9.00 | $15.000300 | 0% | Dec 2024 |
|